Phase 1 Alzheimer's Disease Trial, Recruiting NCT07580703 Sponsor: Eli Radiopharma Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 1 Alzheimer's Disease Trial, Recruiting

NCT07580703
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be willing and able to sign a consent form agreeing to take part in the study.
  • You must be between 50 and 85 years old (male or female).
  • You must have enough education to be able to complete memory and thinking tests reliably.
  • You must fall into one of three groups: (1) no memory or thinking problems, with normal brain scan results; (2) mild memory or thinking problems that may be related to Alzheimer's disease, with specific brain scan findings; or (3) a diagnosis of probable Alzheimer's disease, with specific brain scan findings.
  • If you are able to have children, you must agree not to try to get pregnant or donate sperm or eggs during the study and for 6 months after, and to use effective birth control (including your partner).

Who may not be able to join:

  • Women who are pregnant or breastfeeding.
  • Anyone who has had a major operation in the last month, or who has a surgery planned during the study.
  • Anyone with a known allergy to the radioactive scan injection used in the study, alcohol, or related substances, or who has had serious allergic reactions to similar things.
  • Anyone whose memory or thinking problems are caused by something other than Alzheimer's disease.
  • Anyone who has had a significant stroke or is thought to have dementia caused by multiple strokes.
  • Anyone currently experiencing a significant mental health condition, such as severe depression or schizophrenia.
  • Anyone with a history of epilepsy or seizures (except for febrile seizures — fever-related seizures — in childhood).
  • Anyone who is unable to have a PET or MRI brain scan, or for whom these scans are not safe (confirm with trial site).
  • Anyone with a brain or nerve condition other than Alzheimer's disease that causes memory or thinking problems.
  • Anyone the study doctor feels would not be suitable for the study for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Eli Radiopharma
Registry
ClinicalTrials.gov
Start date
23 April 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence and Severity of Treatment-Emergent Adverse Events (TEAEs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov